SG Americas Securities
ENTX icon

SG Americas Securities’s Entera Bio ENTX Stock Holding History

SG Americas Securities’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Buy
+13,913
New +$17.4K ﹤0.01% 3251

Other funds holding ENTX

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

SG Americas Securities's ENTX Position: Q2 2026 in Review

SG Americas Securities opened a new position in Entera Bio (ENTX) in Q2 2026: 13,913 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #3251 among its holdings.

15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • SG Americas Securities held 13,913 shares of Entera Bio worth $25K as of Q2 2026.
  • Entera Bio was a new SG Americas Securities position in Q2 2026.
  • Entera Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3251 holding.
  • 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.